Modulation of NLRP3 Inflammasome by Physical Exercise in Systemic Arterial Hypertension: a scoping Review

  • Danilo Farias de Morais Discente no Mestrado em Biotecnologia e Inovação em Saúde da Universidade Anhanguera de São Paulo (UNIAN-SP), Brasil.
  • Susana Nogueira Diniz Doutora do Programa de Biotecnologia e Inovação em Saúde da Universidade Anhanguera de São Paulo (UNIAN-SP), Brasil.
Keywords: Inflammation, Exercise, Arterial hypertension

Abstract

A modulation of tissue inflammatory processes is widely studied given its relevance in various pathologies, including systemic arterial hypertension (SAH). The NLRP3 complex (NOD-like receptor family, pyrin domain containing 3) activates caspase 1, resulting in the cleavage and activation of important mediators of the inflammatory response, such as interleukins (IL) 1beta and IL-18. Physical exercise, besides being a low-cost and easily accessible therapy for the population, represents an effective form of treatment and prevention for SAH. Recently, there has been a growing interest in studying the relationship between physical exercise and inflammation modulation. However, few studies have investigated the association of the NLRP3 inflammasome with inflammatory processes, including SAH, in response to exercise. Therefore, this study aimed to conduct a comprehensive review to characterize the modulation of the NLRP3 inflammasome through physical exercise in SAH. The methodology adopted followed a protocol based on the Problem, Concept, and Context (PCC) approach, with a search conducted in the PubMed, Cochrane, and LILACS databases, covering the period from October 2020 to 2023. Ten studies that met the inclusion criteria were carefully selected. The results revealed an efficient response in reducing endothelial inflammation with aerobic exercise intervention. The systematization of the information obtained in this study may contribute to the identification of types and protocols of physical activities capable of modulating the inflammatory response and the NLRP3 inflammasome, with potential application in SAH treatment

References

-Broz, P.; Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nature reviews. Immunology. Vol. 16. Num. 7. 2016. p. 407-420.

-Butts, B.; Butler, J.; Dunbar, S.B.; Corwin, E.J.; Gary, R.A.ASC methylation and interleukin-1a are associated with aerobic capacity in heart failure. Medicine and science in sports and exercise. Vol. 49. Num. 4. 2017. p.1072-1078.

-Butts, B.; Butler, J.; Dunbar, S.B.; Corwin, E.J.; Gary, R.A.ASC methylation and interleukin-1a are associated with aerobic capacity in heart failure. Medicine and science in sports and exercise. Vol. 50. Num. 9. 2018. p.1757-1766.

-Butts, B.; Gary, R.A.; Dunbar, S.B.; Butler, J.; ASC methylation and interleukin-1a are associated with aerobic capacity in heart failure. Medicine and science in sports and exercise. Vol. 22. Num. 5. 2016. p. 340-346.

-Camell, C.D.; Sander, J.; Spadaro, O.; Lee, A.; Nguyen, K.Y.; Wing, A. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature. Vol. 5. Num. 550. 2017. p. 119-123.

-Cai, A.; Calhoun, D. A. Resistant hypertension: an update of experimental and clinical findings. Hypertension. Vol. 70. Num. 1. 2017. p. 5-9.

-Caspersen, C.J.; Powell, K.F.; Christenson, G.M.; Physical activity, exercise and physical fitness: definitions and distinctions for health-related research. Public Health Reports. Vol. 100. Num. 2. 1985. p. 126-131.

-Comassi, M.; Santini, E.; Rossi, C.; Vitolo, E.; Seghieri, M.; Tocchini, L. The level of physical training modulates cytokine levels through P2X7 receptor in healthy subjects. European journal of clinical investigation. Vol. 48. Num. 2. 2018.

-Davis, B. K.; Wen, H.; Ting, J. P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annual review of immunology. Vol. 29. Num. 1. 2011. p.707-735.

-Ferrier, D.R. Bioquímica Ilustrada. Porto Alegre. Artmed. 2018. p. 278.

-Drummond, G.R.; Vinh, A.; Guzik, T.J.; Sobey, C.G. Immune mechanisms of hypertension. Nature reviews. Immunology. Vol. 19. Num. 8. 2019. p. 517-532.

-Dubuisson, N.; Versele, R.; Davis, L.C.; Selvais, C.M.; Brichard, S.M. Walking down Skeletal Muscle Lane: From Inflammasome to Disease. Cells. Vol. 10. Num. 11. 2021.

-GBD. Global Burden of Disease. Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. Vol. 388. 2016. p. 1659-1724.

-Harrison, D.G.; The immune system in hypertension. Transactions of the American Clinical and Climatological Association. Vol. 125. Num. 1. 2014. p. 130-140.

-Liu, P.; Huang, G.; Wei, T.; Gao, J.; Huang, C.; Sun, M.; Zhu, L.; Shen, W. Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation. Biochimica et biophysica acta. Molecular basis of disease. Vol. 1864. Num. 1. 2018. p. 764-777.

-Lv, Z.; Wang, Y.; Liu, Y.J.; Mao, Y.F.; Dong, W.W.; Ding, Z.N.; Meng, G. X.; Jiang, L.; Zhu, X. Y. NLRP3 Inflammasome A ctivation Contributes to Mechanical Stretch-Induced Endothelial-Mesenchymal Transition and Pulmonary Fibrosis. Critical care medicine. Vol. 46. Num. 1. 2018. p. 49-58.

-Maior, A.S. Fisiologia dos exercícios resistidos 2ª edição revista e ampliada. São Paulo. Phorte. 2013. p. 28.

-Martinon, F.; Burns, K.; Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell. Vol. 10. Num. 2. 2002. p. 417-426.

-Medzhitov, R. Origin and physiological roles of inflammation. Nature. Vol. 454. Num. 2. 2008. p. 428-435.

-Medzhitov, R.; Janeway, C.A.Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. Vol. 91. Num. 2. 1997. p. 295-298.

-Murphy, K. M.; Weaver, C. Janeway's immunobiology. Nova York. Garland Science. 2017. p. 128.

-Organização Mundial da Saúde. Portal da OMS. Orientações sobre Hipertensão. Genebra. 2021.

-Organização Pan Americana de Saúde. Portal da OPAS. Mundo tem mais de 700 milhões de pessoas com hipertensão não tratada. Acervo digital. 2021.

-Pereira, B. Mitocôndria: a casa de força da potência aeróbia e da resistência. Curitiba. CRV. 2018. p. 18.

-Peters, M.D.J.; Godfrey, C.; Mclnerney, P; Soares. C.B.; Khalil, H.; Parker, D. Chapter 11: Scoping Reviews. IN Aromataris, E.; Munn, Z. Joanna Briggs Institute Reviewer's Manual. JBI. 2017.

-Ribeiro, R. C.; Lotufo, P. A. Hipertensão arterial: diagnóstico e tratamento. São Paulo. Sarvier. 2005. p. 36.

-Shephard, R.J.; Balady, G. Exercise as cardiovascular therapy. Circulation. Vol. 99. Num. 7. 1999. p. 963-972.

-Whelton, P.K.; Carey, R.M.; Aronow, W.S.; Casey, D.E.Jr.; Collins, K.J.; Himmelfarb, C.D.; Palma, S.M.; Gidding, S.; Jamerson, K.A.; Jones, D.W.; MacLaughlin, E.J.; Muntner, P.; Ovbiagele, B.; Smith, S.C.Jr.; Spencer, C.C.; Stafford, R.S.; Taler, S.J.; Thomas, R.J.; Williams, K.A.Sr.; Williamson, J.D.; Wright, J.T.Jr. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. Vol. 72. Num. 1. 2018. p. 1269-1324.

-Zhang, Z.T.; Du, X.M.; Ma, X.J.; Zong, Y.; Chen, J.K.; Yu, C.L.; Liu, Y.G.; Chen, Y.C.; Zhao, L.J.; Lu, G.C. Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome. Journal of Neuroinflammation. Vol. 13. Num. 1. 2016. p. 71.

Published
2023-12-28
How to Cite
Morais, D. F. de, & Diniz , S. N. (2023). Modulation of NLRP3 Inflammasome by Physical Exercise in Systemic Arterial Hypertension: a scoping Review. Brazilian Journal of Exercise Prescription and Physiology, 17(112), 548-566. Retrieved from https://www.rbpfex.com.br/index.php/rbpfex/article/view/2831
Section
Scientific Articles - Original